WuXi AppTec A, headquartered in CN, is a global pharmaceutical contract research, development, and manufacturing organization. The company provides comprehensive R&D and manufacturing solutions, supporting the development of innovative medicines from discovery through production, including novel cell and gene therapies, for the global healthcare industry.
Date confirmed from the official Chinese exchange disclosure timetable.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
WuXi AppTec A is scheduled to report its next quarterly earnings on 10/27/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
WuXi AppTec A last reported quarterly earnings on 8/3/2026 (Q2 2026). Earnings per share (EPS) came in at 2.18 CNY.
Across its last 4 earnings reports, WuXi AppTec A stock moved by ±1.2% on average the following day. The largest reaction was -3.4% on 03/23/2026; 3 of 4 reactions were positive.
WuXi AppTec A has beaten analyst EPS estimates in 4 of its last 5 evaluated quarters (beat rate: 80%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 4 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.